Monday 18th January 2021 GatewayC have produced a list of cancer charity support lines for people who may be worried about their cancer diagnosis, or are concerned about how COVID-19 might affect their cancer treatment. Please download this PDF resource or find the...
15th January 2021 Missed our free GatewayC webinar on Diagnosing Ovarian Cancer? Watch our recording here. In this webinar, GatewayC met Professor Gordon Jayson, Professor of Medical Oncology at The Christie NHS Foundation Trust, who answered key questions from our...
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Whilst FIT can be a good indicator of bowel cancer, inflammatory bowel disease and sometimes precursors of cancer, some symptomatic patients can still have false negative results. With this in mind, how should you proceed?
A normal result can miss colorectal cancer, as can a colonoscopy. Reassess patients with a negative FIT result who continue to experience symptoms. Consider referral onto a vague symptoms pathway or tests for other bowel conditions.
Safety netting for symptomatic patients with negative FIT results include ensuring patients are aware they need to come back if they continue to experience symptoms and keep their own record through the use of a symptom diary.
Download this Cancer Key here.
Access GatewayC’s course on FIT here.